Skip to content
Search

Latest Stories

Top Stories

Americans are mostly worried about poor leadership and inflation

concerns about government
Sky Noir Photography by Bill Dickinson/Getty Images

While concerns about inflation have skyrocketed since January, more Americans remain concerned about government than any other challenge facing the nation, according to a new poll.

Twenty-two percent of Americans told Gallup pollsters in March that government and poor leadership is the most important problem in the United States. That’s the sixth consecutive month in which at least one-fifth of Americans chose that response.


More than three times as many white people than people of color said government was the biggest problem, and that answer was 30 percent more common among Republicans than Democrats.

Selection of “unifying the country” has declined slightly, from 7 percent in January to 5 percent in March, well within the margin of error.

Economic issues overall were a more common answer, with 37 percent of respondents selecting among a number of topics. Inflation was the most popular of those answers, selected by 17 percent — up from 8 percent in January.

The Consumer Price Index, which measures inflation, reached 7.9 percent in February. That’s the highest rate in 40 years.

The coronavirus and disease in general is no longer a major concern among Americans. In January, when the latest Covid-19 wave peaked, 20 percent said it was the biggest problem facing the country. That dropped to 3 percent in March.

Gallup served 1,017 adults March 1-18. The survey has a margin of error of 4 percentage points.

Read More

The Battle Over Truth: Trump, Data, and the Fight for Reality
File:Donald Trump (29496131773).jpg - Wikimedia Commons

The Battle Over Truth: Trump, Data, and the Fight for Reality

I. The Battle Over Facts

When Donald Trump fired Dr. Kristine Joy Suh, head of the Bureau of Labor Statistics, after a disappointing July jobs report, it wasn’t merely a personnel decision—it was a sharp break with precedent. Suh’s removal upended decades of tradition in which BLS commissioners, regardless of who appointed them, were shielded from political retaliation to preserve statistical integrity. In his second term, Trump has made it clear that data isn’t merely information to be reported—it’s a narrative to be controlled. If the numbers align with his message, they’re hailed as proof of success. If they don’t, they’re dismissed as fake—or worse, subversive.

Keep ReadingShow less
Time to Toughen Up: Democrats Face a Crossroads

Democrats Donkey lifts weights

Time to Toughen Up: Democrats Face a Crossroads

As the 2026 midterms loom, a simmering debate within Democratic circles has reached a boiling point: Should the party abandon the moral high ground and play political hardball?

In recent years, Democrats have leaned heavily on the ethos of civility and hope—famously embodied by Michelle Obama’s 2016 rallying cry, “When they go low, we go high.” But with the GOP embracing increasingly combative rhetoric and tactics, some strategists argue it’s time for Democrats to recalibrate their messaging—and their muscle.

Keep ReadingShow less
Trump’s Drug Price Ultimatum and the Rise of Enemy Politics
shallow focus photography of prescription bottle with capsules

Trump’s Drug Price Ultimatum and the Rise of Enemy Politics

In an era increasingly defined by transactional politics, the rhetoric of ultimatum has become one of President Donald Trump's favorite tools. When he declared to pharmaceutical giants on August 1st, "We will deploy every tool in our arsenal" should they fail to lower drug prices, it echoed a familiar pattern of the use of "demand" to shift from negotiation to confrontation. Trump's all-too-familiar pattern of prescribing with deadlines, threats of tariffs or sanctions, and appeals to fairness or national pride.

In his letter to 17 major drug manufacturers, Trump demanded that drug manufacturers slash prices to match "most favored nation" levels—the lowest rates offered in other developed countries. He emphasized that Americans are "demanding lower drug prices and they need them today." His language, though cloaked in populist concern, carried a veiled threat:

Keep ReadingShow less